Analyst Research Report Snapshot

Title:

EFII: 4Q12 review; revise 2013E; initiate 2014E; increase PO

Price:

$81.00

Provider:

Griffin Securities, Inc.

Date:

25 Jan 2013

Pages:

9

Type:

AcrobatPDF

Companies referenced:

EFII.OQ

Available for Immediate Download
Summary:

We are updating coverage on Electronics for Imaging, Inc. (EFII) with a BUY rating, and we are increasing our 18-month price target to $27.00 from $22.00 for EFII shares for the following reasons: • 4Q 2012 was the twelfth consecutive quarter exhibiting top line growth, rising 7% yr/yr- vs. guidance of +1-4%; • New product introductions to drive further growth for industrial inkjet (as well as Fiery)- new high end digital color printer introductions by OEM’s in 1H ’13 will aid Fiery, particularly as we approach 2Q ‘13; • $7.67 in cash & short term investments- buttressed by $3/share (net of taxes) on sale of headquarter building & $28 million in cash generated 4Q ‘12- total cash equates to 39% of stock price (co. has zero debt); • During last 4 months of ’12 EFII repurchased $23 million of its stock of recently instituted $100 million share repurchase- ultimately expect dividend to be established as a result of real estate sale; • Discretionary free C/F generation impressive- revenue decline of 28% during ’09 resulted in only modest cash burn of $25 million, or $0.50/share. Generated free C/F of $1.05 during 2010, $1.31 ’11, $1.25 ’12 & project $1.38 for ’13, and; • Introducing preliminary estimate for 2014 of $1.58.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.